These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 14517353)
21. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
22. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease. Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705 [TBL] [Abstract][Full Text] [Related]
23. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Klunk WE; Wang Y; Huang GF; Debnath ML; Holt DP; Mathis CA Life Sci; 2001 Aug; 69(13):1471-84. PubMed ID: 11554609 [TBL] [Abstract][Full Text] [Related]
24. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model. Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237 [TBL] [Abstract][Full Text] [Related]
25. Fluorescent Imaging of Amyloid-β Deposits in Brain: An Overview of Probe Development and a Highlight of the Applications for In Vivo Imaging. Fu H; Cui M Curr Med Chem; 2018; 25(23):2736-2759. PubMed ID: 29446721 [TBL] [Abstract][Full Text] [Related]
26. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease. Bi Oh S; Suh N; Kim I; Lee JY Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of 18F-labelled 2-(4'-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB. Serdons K; Verduyckt T; Vanderghinste D; Cleynhens J; Borghgraef P; Vermaelen P; Terwinghe C; Van Leuven F; Van Laere K; Kung H; Bormans G; Verbruggen A Bioorg Med Chem Lett; 2009 Feb; 19(3):602-5. PubMed ID: 19147351 [TBL] [Abstract][Full Text] [Related]
28. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain. Ni R; Marutle A; Nordberg A J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213 [TBL] [Abstract][Full Text] [Related]
29. Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy. Burgess A; Nhan T; Moffatt C; Klibanov AL; Hynynen K J Control Release; 2014 Oct; 192():243-8. PubMed ID: 25107692 [TBL] [Abstract][Full Text] [Related]
30. Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice. Lillehaug S; Syverstad GH; Nilsson LN; Bjaalie JG; Leergaard TB; Torp R Neurobiol Aging; 2014 Mar; 35(3):556-64. PubMed ID: 24126157 [TBL] [Abstract][Full Text] [Related]
31. 19F and 1H MRI detection of amyloid beta plaques in vivo. Higuchi M; Iwata N; Matsuba Y; Sato K; Sasamoto K; Saido TC Nat Neurosci; 2005 Apr; 8(4):527-33. PubMed ID: 15768036 [TBL] [Abstract][Full Text] [Related]
33. Targeting prion amyloid deposits in vivo. Sadowski M; Pankiewicz J; Scholtzova H; Tsai J; Li Y; Carp RI; Meeker HC; Gambetti P; Debnath M; Mathis CA; Shao L; Gan WB; Klunk WE; Wisniewski T J Neuropathol Exp Neurol; 2004 Jul; 63(7):775-84. PubMed ID: 15290902 [TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Ansciaux E; Burtea C; Laurent S; Crombez D; Nonclercq D; Vander Elst L; Muller RN Contrast Media Mol Imaging; 2015; 10(3):211-24. PubMed ID: 25284012 [TBL] [Abstract][Full Text] [Related]
35. Fluorescence resonance energy transfer determinations using multiphoton fluorescence lifetime imaging microscopy to characterize amyloid-beta plaques. Bacskai BJ; Skoch J; Hickey GA; Allen R; Hyman BT J Biomed Opt; 2003 Jul; 8(3):368-75. PubMed ID: 12880341 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of styrylpyran fluorophores for noninvasive detection of cerebral β-amyloid deposits. Zhu BY; Cheng Y; Li GB; Yang SY; Zhang ZR Bioorg Med Chem; 2016 Feb; 24(4):827-34. PubMed ID: 26774253 [TBL] [Abstract][Full Text] [Related]
37. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Mathis CA; Bacskai BJ; Kajdasz ST; McLellan ME; Frosch MP; Hyman BT; Holt DP; Wang Y; Huang GF; Debnath ML; Klunk WE Bioorg Med Chem Lett; 2002 Feb; 12(3):295-8. PubMed ID: 11814781 [TBL] [Abstract][Full Text] [Related]
38. Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition. Condello C; Schain A; Grutzendler J Sci Rep; 2011; 1():19. PubMed ID: 22355538 [TBL] [Abstract][Full Text] [Related]
39. Filamentous phage as vector-mediated antibody delivery to the brain. Frenkel D; Solomon B Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5675-9. PubMed ID: 11960022 [TBL] [Abstract][Full Text] [Related]
40. Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions? Savory J; Ghribi O; Herman MM Neurobiol Aging; 2002; 23(6):1089-92. PubMed ID: 12470807 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]